Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $60
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $55 to $60.
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $55 to $60.